Pseudomonas aeruginosa aggregates elicit neutrophil swarming

Eliana Drenkard1,2, Christian Godfrey2,3,4, Alex Hopke2,3,4

  • 1Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston MA 02114, USA.

Iscience
|February 19, 2025
PubMed

Insights

A new ex vivo model effectively captures neutrophil swarming against Pseudomonas aeruginosa aggregates. This breakthrough aids in understanding host-pathogen interactions and developing treatments for multidrug-resistant infections.

Area of Science:

  • Immunology
  • Microbiology
  • Pathogen Research

Background:

  • Pseudomonas aeruginosa is a high-risk, multidrug-resistant pathogen.
  • Neutrophil swarming is a critical host defense mechanism against pathogens.
  • Existing ex vivo models do not adequately replicate neutrophil swarming dynamics.

Purpose of the Study:

  • To develop a novel ex vivo model for studying neutrophil swarming.
  • To investigate the interaction between neutrophils and bacterial aggregates.
  • To identify P. aeruginosa factors involved in neutrophil swarm responses.

Main Methods:

  • Development of a reproducible ex vivo model.
  • Utilizing bacterial aggregates as targets for neutrophil swarming.
  • Analysis of neutrophil-pathogen interactions and P. aeruginosa virulence factors.

Main Results:

  • The model reproducibly elicits neutrophil swarming against bacterial aggregates.
  • A rapid and robust swarming response was observed.
  • Components of the type III secretion system (T3SS) were implicated in swarm interactions.

Conclusions:

  • The developed ex vivo model is a valuable tool for studying neutrophil swarming.
  • This model facilitates the elucidation of host-pathogen interaction mechanisms.
  • The model can be used to evaluate novel therapeutics against multidrug-resistant infections.